Report: J&J recalls thousands of hip implants

(AP)—A German newspaper reports that Johnson & Johnson is recalling thousands of hip implants 2 1/2 years after a similar recall.

Handelsblatt reports that the Adept made by J&J's subsidiary DePuy Orthopaedics showed a failure rate of 12 percent after seven years. It said some 7,500 of the implants were shipped worldwide between 2004 and 2011.

Johnson & Johnson representatives in Germany and the United States didn't immediately respond to requests for comment.

Germany's Federal Institute for Drugs and Medical Devices on Thursday confirmed it had received a notice from Johnson & Johnson about the recall.

In August 2010, J&J recalled two types of DePuy ASR metal hip implants after they were linked to high failure rates. J&J has had more than 30 other product recalls since 2009.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

'Hundreds of thousands' fitted with suspect hip implants

Feb 28, 2012

Hundreds of thousands of people have been fitted with replacement hips whose flawed design may be exposing them to toxic metal, according to a probe by the BBC and the British Medical Journal (BMJ) unveiled Tuesday.

UK says metal hip replacements more troublesome

Sep 16, 2011

(AP) -- People who get metal hip replacements are more likely to need a replacement compared to those who get a traditional plastic one, according to a new report from a large British registry.

FDA probing safety of metal-on-metal hip implants

Jun 27, 2012

(HealthDay) -- While thousands of Americans have benefited from hip replacements over the years, problems with metal-on-metal implants can lead to troubles requiring surgery to replace defective devices, experts ...

Recommended for you

Errata frequently seen in medical literature

11 hours ago

(HealthDay)—Errata, including those that may materially change the interpretation of data, are frequent in medical publications, according to a study published in the August issue of The American Journal of ...

Seven US-based researchers share $1.3M eyesight prize

Sep 10, 2014

Seven U.S.-based researchers are sharing a €1 million ($1.3 million) prize from a Portuguese foundation for their work developing treatment for angiogenic diseases of the retina, the leading cause of blindness in the developed ...

User comments